BioPharmSignal logoBioPharmSignal

Biotech News

LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2026

Lifevantage (LFVN)LifevantageEarnings

SALT LAKE CITY, Aug. 27, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its fourth fiscal quarter ended June 30, 2026.

Related news

LFVNLifevantage2026-05-06 20:05 EST

LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2026

LFVNLifevantage2026-02-04 21:04 EST

LifeVantage Announces Financial Results for the Second Quarter of Fiscal 2026

View all latest news

Lifevantage

Direct-Selling Wellness Company LifeVantage develops and markets nutritional supplements and personal-care products through a network of independent consultants. Nutrigenomics Positioning The company's products are marketed around activation of cellular pathways associated with antioxidant response, metabolism and healthy aging rather...

Recent company news

LFVNLifevantage2026-09-18 12:00 EST

LifeVantage to Participate in the WTR Virtual Insights Conference on Wednesday, September 23, 2026

LFVNLifevantage2026-08-27 20:05 EST

LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2026

LFVNLifevantage2026-08-21 12:00 EST

LifeVantage Declares Quarterly Dividend

LFVNLifevantage2026-08-13 20:30 EST

LifeVantage to Announce Fourth Quarter and Full Fiscal Year 2026 Results on August 27, 2026

LFVNLifevantage2026-08-11 21:00 EST

LifeVantage Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Stock data

Close
6.20 USD
Market cap
108.75M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States